AGI.do

Products

What will AGI do for Amebucort?

This classification denotes a therapeutic glucocorticoid with the molecular formula C28H40O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7YRF8G0G0F, chemically known as 11 beta,17,21-trihydroxy-6 alpha-methylpregn-4-ene-3,20-dione 21-acetate 17-butyrate but generally known as amebucort, which bears US NIH Compound Identifier 3086167. European Medicines Agency schedules Amebucort in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05405MIG. The term AMEBUCORT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). AMEBUCORT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amebucort under HS 29372900 and SITC 54153. As of Q4 2014, AMEBUCORT remains the US FDA Preferred Term for this commodity. Amebucort bears US NLM identifiers UMLS ID C2698081 and NCI Concept Code C74406. SMILES: O(C1(C2(C(C3C(C4(C(=CC(=O)CC4)C(C3)C)C)C(O)C2)CC1)C)C(=O)COC(=O)C)C(=O)CCC.

How AGI delivers it

Four ways AGI delivers for Amebucort

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Amebucort, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Amebucort, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Amebucort connects

measured by

  • Active Ingredient Potencymodel
  • Compound Puritymodel
  • Steroid Isomer Puritymodel

Go deeper

Explore Amebucort

Read the deeper take on agi.asView as markdown